149 Startups
  • Sector
  • Participated in
  • Year of participation

Avalanche Medical

  • 2018
  • Medical Device
  • Venture Challenge
Provide pain relief and functional restoration for patients suffering from focal knee cartilage defects, which is a chronic and severely disabling musculoskeletal condition.

AVIGI Therapeutics (formerly known as Triangle Therapeutics)

  • 2023
  • Therapeutics
  • Venture Challenge
Triangle Therapeutics strives to bring breakthrough technology to the clinic that blocks metastasis and thereby significantly enhancing success rates of first-line cancer treatments for patients suffering from metastatic cancers.

Beephonix

  • 2022
  • Medical Device
  • Venture Challenge
Beephonix develops a biomimetic microphones to improve hearing in noisy conditions. The approach mimics the way bees move their antennae.

BI/OND

  • 2016
  • Enabling Technology
  • Venture Challenge
The hardware of choice for OCC in-vitro testing of drug candidates, reducing the incidence of false positives and false negative in pre-clinical trials.

BIMINI Biotech

  • 2019
  • Therapeutics
  • Venture Challenge
BIMINI Biotech is developing therapeutic strategies for major unmet medical needs. Our first development program targets the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases and ageing.

BioGrid

  • 2025
  • Venture Challenge
BioGrid revolutionizes organ-on-chip technology with a scalable, high-throughput platform that enables efficient, versatile drug testing across multiple tissue types.

Biomimiq

  • Enabling Technology
  • Venture Challenge
Biomimiq provides both healthy and diseased in vitro human skin equivalent for animal free compound screening and safety testing services

Biosonics

  • Venture Challenge
Biosonics is building a new class of biomolecular imaging tools that make it possible to visualise cellular activity deep inside living tissue—non-invasively and in real time. Their technology, NSSM, leverages acoustic reporter genes (ARGs): genetically encoded proteins that produce ultrasound contrast when expressed in cells.

Breathomix

  • 2015
  • Diagnostics
  • Venture Challenge
The goal of Breathomix is to bring exhaled breath based diagnosis to medicine in a point of care setting.

CC Diagnostics

  • 2017
  • Diagnostics
  • Venture Challenge
CC Diagnostics offers a superior, easily implementable triage test with an unsurpassed specificity and reproducibility, which will decrease the number of misdiagnosed women, decrease healthcare costs, and increase screening participation.